Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening tests for hepatocellular carcinoma.

Jorge A Marrero1

  • 1Division of Gastroenterology, University of Michigan, Ann Arbor, MI 48109-0362, USA. jmarrero@umich.edu

Clinics in Liver Disease
|April 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review.

Gastroenterology·2026
Same author

Validation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Shifts in Cohort Eligibility With Deimplementation of Race-specific Guidance for Hepatocellular Carcinoma Surveillance.

Gastro hep advances·2025
Same author

HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort.

Journal of hepatology·2025
Same author

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.

Hepatology (Baltimore, Md.)·2025
Same author

AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.

Hepatology (Baltimore, Md.)·2025

Hepatocellular carcinoma (HCC) screening is vital due to rising global incidence. While effective, current surveillance tests for HCC lack optimal accuracy, presenting a key limitation.

Area of Science:

  • Hepatology
  • Oncology
  • Medical Diagnostics

Background:

  • Global incidence of hepatocellular carcinoma (HCC) is increasing.
  • HCC surveillance is recommended for patients with cirrhosis.
  • Early diagnosis and treatment of HCC improve outcomes.

Purpose of the Study:

  • To review currently available diagnostic tests for HCC surveillance.
  • To discuss the accuracy limitations of existing HCC screening methods.

Main Methods:

  • Literature review of diagnostic tests for HCC surveillance.
  • Analysis of accuracy and cost-effectiveness of screening modalities.

Main Results:

  • Surveillance for HCC meets most criteria for effective screening.

Related Experiment Videos

  • Alpha-fetoprotein and ultrasound are cost-effective surveillance tools.
  • The primary limitation of HCC surveillance is the accuracy of screening tests.

    • Conclusions:

    • Despite limitations in accuracy, HCC surveillance is crucial.
    • Further research into improving the accuracy of HCC screening tests is needed.
    • Optimizing surveillance strategies can improve patient outcomes for HCC.